Literature DB >> 25398293

Fontan-like circulation as a criterion for heart transplantation in arrhythmogenic right ventricular dysplasia.

Christiana Schernthaner1, Gerhard Poelzl, Bernhard Strohmer, Richard Steinacher, Marcel Granitz, Johann Altenberger.   

Abstract

BACKGROUND: Arrhythmogenic right ventricular dysplasia (ARVD) is often associated with progressive right ventricular dysfunction. Although heart transplantation (HTx) is suggested in these patients, indication and optimal timing for listing can be challenging. METHODS AND
RESULTS: The study comprises four patients (two male, range: 37-56 years) with advanced ARVD who were considered for HTx. Standard inclusion criteria for HTx listing such as clinical signs, New York Heart Association (NYHA) classification (II-III), and N-terminal pro-brain natriuretic peptide (NT-proBNP) (3672 ± 1407 pg/ml) were heterogeneous and did not add unequivocally to decision making. In all patients, though, right heart hemodynamics revealed Fontan-like circulation (FLC) with equilibrated pressure tracings between the right atrium (16 ± 4 mmHg) and the pulmonary artery (16 ± 5 mmHg). In this condition, the pulmonary blood flow can be regarded as nearly non-pulsatile, as it is passive and propelled by the transpulmonary gradient and intrathoracic pressure alterations produced by breathing to the left atrium. Based on these findings, all patients were listed for HTx and were finally successfully transplanted.
CONCLUSIONS: In patients with ARVD, evidence of FLC may serve as an additional criterion for HTx. This applies particularly to patients who do not clearly fulfill standard transplant criteria and to patients with electrical instability.

Entities:  

Mesh:

Year:  2014        PMID: 25398293     DOI: 10.1007/s00508-014-0656-8

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  17 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

2.  Arrhythmogenic right ventricular dysplasia: a United States experience.

Authors:  Darshan Dalal; Khurram Nasir; Chandra Bomma; Kalpana Prakasa; Harikrishna Tandri; Jonathan Piccini; Ariel Roguin; Crystal Tichnell; Cynthia James; Stuart D Russell; Daniel P Judge; Theodore Abraham; Philip J Spevak; David A Bluemke; Hugh Calkins
Journal:  Circulation       Date:  2005-12-12       Impact factor: 29.690

3.  Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry.

Authors:  Bruno Pinamonti; Andreea Mihaela Dragos; Stylianos A Pyxaras; Marco Merlo; Alberto Pivetta; Giulia Barbati; Andrea Di Lenarda; Tullio Morgera; Luisa Mestroni; Gianfranco Sinagra
Journal:  Eur Heart J       Date:  2011-02-28       Impact factor: 29.983

4.  Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.

Authors:  Stuart J Pocock; Cono A Ariti; John J V McMurray; Aldo Maggioni; Lars Køber; Iain B Squire; Karl Swedberg; Joanna Dobson; Katrina K Poppe; Gillian A Whalley; Rob N Doughty
Journal:  Eur Heart J       Date:  2012-10-24       Impact factor: 29.983

5.  Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Ryan J Tedford; Cynthia James; Daniel P Judge; Crystal Tichnell; Brittney Murray; Aditya Bhonsale; Binu Philips; Theodore Abraham; Darshan Dalal; Marc K Halushka; Harikrishna Tandri; Hugh Calkins; Stuart D Russell
Journal:  J Am Coll Cardiol       Date:  2012-01-17       Impact factor: 24.094

6.  Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia.

Authors:  Jonathan P Piccini; Darshan Dalal; Ariel Roguin; Chandra Bomma; Alan Cheng; Kalpana Prakasa; Jun Dong; Crystal Tichnell; Cynthia James; Stuart Russell; Jane Crosson; Ronald D Berger; Joseph E Marine; Gordon Tomaselli; Hugh Calkins
Journal:  Heart Rhythm       Date:  2005-11       Impact factor: 6.343

7.  Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression.

Authors:  Srijita Sen-Chowdhry; Petros Syrris; Deirdre Ward; Angeliki Asimaki; Elias Sevdalis; William J McKenna
Journal:  Circulation       Date:  2007-03-19       Impact factor: 29.690

8.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

Review 9.  Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Jean-Sébastien Hulot; Xavier Jouven; Jean-Philippe Empana; Robert Frank; Guy Fontaine
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

10.  Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Domenico Corrado; Loira Leoni; Mark S Link; Paolo Della Bella; Fiorenzo Gaita; Antonio Curnis; Jorge Uriarte Salerno; Diran Igidbashian; Antonio Raviele; Marcello Disertori; Gabriele Zanotto; Roberto Verlato; Giuseppe Vergara; Pietro Delise; Pietro Turrini; Cristina Basso; Franco Naccarella; Francesco Maddalena; N A Mark Estes; Gianfranco Buja; Gaetano Thiene
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

View more
  1 in total

Review 1.  Arrhythmogenic Right Ventricular Dysplasia in Neuromuscular Disorders.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Clin Med Insights Cardiol       Date:  2016-10-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.